Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva

被引：0
|
作者：
Fabinshy Thangarajah
Bernd Morgenstern
Caroline Pahmeyer
Lars Mortimer Schiffmann
Julian Puppe
Peter Mallmann
Stefanie Hamacher
Reinhard Buettner
Christina Alidousty
Barbara Holz
Andreas H. Scheel
Anne Maria Schultheis
机构：
[1] University of Cologne,Department of Obstetrics and Gynaecology, Medical Faculty, University Hospital Cologne
[2] University of Cologne,Department of General, Visceral and Cancer Surgery
[3] University Hospital Cologne,Institute of Medical Statistics and Computational Biology
[4] Institute of Pathology,Department of Pathology, University Hospital of Cologne
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
Vulvar carcinoma; PD-L1; PD-1; HPV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1651 / 1660
页数：9
相关论文
共 50 条
  • [31] Expression of PD-L1 and PD-1 in conjunctival melanoma
    Cao, Jinfeng
    Richards, Kate
    Jordanova, Ekaterina S.
    Arinkovic, Marina
    Hurkmans, Daan
    van Duinen, Sjoerd G.
    van der Velden, Pieter A.
    Jager, Martine J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [32] Expression of PD-L1 and PD-1 in Cutaneous Warts
    Yu, Wesley
    Berger, Timothy
    Laszik, G. Zoltan
    North, Jeffrey
    Cohen, Jarish
    MODERN PATHOLOGY, 2019, 32
  • [33] Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
    Shen, Xian
    Zhao, Bin
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
  • [34] CLINICAL CORRELATIONS OF PD-1 AND PD-L1 EXPRESSION IN PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS (LCH)
    Tandon, Sneha
    Joyce, Brooklyn
    Hawkins, Cynthia
    Weitzman, Sheila
    Whitlock, Jim
    Ngan, Bo
    Abla, Oussama
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S32 - S32
  • [35] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    de Souza Malaspina, Tatiana Salles
    Gasparoto, Thais Helena
    Sales Nogueira Costa, Maria Renata
    de Melo, Edgard Franco, Jr.
    Valerio Ikoma, Maura Rosane
    Damante, Jose Humberto
    Cavassani, Karen Angelica
    Garlet, Gustavo Pompermaier
    da Silva, Joao Santana
    Campanelli, Ana Paula
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) : 965 - 974
  • [36] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    Tatiana Salles de Souza Malaspina
    Thaís Helena Gasparoto
    Maria Renata Sales Nogueira Costa
    Edgard Franco de Melo
    Maura Rosane Valério Ikoma
    José Humberto Damante
    Karen Angélica Cavassani
    Gustavo Pompermaier Garlet
    João Santana da Silva
    Ana Paula Campanelli
    Cancer Immunology, Immunotherapy, 2011, 60 : 965 - 974
  • [37] PD-1/PD-L1 Axis in Lung Cancer
    Santini, Fernando C.
    Hellmann, Matthew D.
    CANCER JOURNAL, 2018, 24 (01): : 15 - 19
  • [38] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [39] Antagonists of PD-1 and PD-L1 in Cancer Treatment
    Lipson, Evan J.
    Forde, Patrick M.
    Hammers, Hans-Berg
    Emens, Leisha A.
    Taube, Janis M.
    Topalian, Suzanne L.
    SEMINARS IN ONCOLOGY, 2015, 42 (04) : 587 - 600
  • [40] PD-1/PD-L1 Pathway in Breast Cancer
    Schuetz, Florian
    Stefanovic, Stefan
    Mayer, Luisa
    von Au, Alexandra
    Domschke, Christoph
    Sohn, Christof
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (05) : 294 - 297
12345